Department of Public Health, Amsterdam University Medical Centre (UMC), University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
Department of Internal and Vascular Medicine, Amsterdam UMC, University of Amsterdam, Cardiovascular Sciences, Amsterdam, the Netherlands.
JAMA Netw Open. 2021 Oct 1;4(10):e2128985. doi: 10.1001/jamanetworkopen.2021.28985.
Serum uric acid (SUA) level is associated with vascular dysfunction in Eurasian populations, but little is known about this association in individuals from sub-Saharan Africa, who have a high prevalence of both relatively high SUA levels and vascular dysfunction.
To assess the associations of SUA levels with macrovascular and kidney microvascular dysfunction in individuals of sub-Saharan African ancestry and evaluate potential factors that could mediate these associations.
DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional analyses of baseline data from the multicenter Research on Obesity and Diabetes Among African Migrants study, conducted from 2012 to 2015, were performed from January to March 2021. The population included Ghanaian individuals living in Ghana and Europe.
Abnormal SUA levels.
Logistic regression was used to examine the associations of SUA level quartiles with microvascular (albuminuria) and macrovascular (peripheral artery disease and coronary artery disease) dysfunction, with adjustments for age, sex, estimated glomerular filtration rate, site of residence, socioeconomic status, alcohol, smoking, diabetes, hypertension, waist-hip ratio, and total cholesterol level. Mediation analysis was performed to assess whether the association was via elevated blood pressure, hemoglobin A1c, and high-sensitivity C-reactive protein levels or via weight-hip ratio. The research questions were formulated after data collection.
A total of 4919 Ghanaian individuals (3047 [61.9%] women) aged 25-75 years (mean [SD], 46.26 [11.08] years) were included. There was a significant positive association between SUA quartiles and albuminuria, but not coronary artery disease or peripheral artery disease, after adjustment for covariates. After full adjustment, individuals in the fourth SUA quartile had higher odds of albuminuria (adjusted odds ratio [aOR], 1.54; 95% CI, 1.07-2.21), but not peripheral artery disease (aOR, 1.35; 95% CI, 0.87-2.08) or coronary artery disease (aOR, 1.09; 95% CI, 0.77-1.55), compared with individuals in the first quartile. After full adjustment, systolic and diastolic blood pressure significantly mediated the association between SUA concentrations and albuminuria, accounting for 19.4% of the total association for systolic and 17.2% for diastolic blood pressure; hemoglobin A1c, high-sensitivity C-reactive protein, and waist-hip ratio did not mediate this association.
In this cross-sectional study among a sub-Saharan African population, elevated SUA levels were significantly associated with kidney microvascular dysfunction and mediated partly through elevated blood pressure. These findings suggest that individuals from sub-Saharan Africa with elevated SUA levels may benefit from periodic screening for kidney microvascular dysfunction to aid early detection or treatment.
血清尿酸(SUA)水平与欧亚人群的血管功能障碍有关,但在血尿酸水平相对较高且血管功能障碍高发的撒哈拉以南非洲人群中,人们对此知之甚少。
评估 SUA 水平与撒哈拉以南非洲人群的大血管和肾脏微血管功能障碍的关联,并评估可能介导这些关联的潜在因素。
设计、地点和参与者:对 2012 年至 2015 年期间进行的多中心肥胖和糖尿病研究中非洲移民研究的基线数据进行了横断面分析,于 2021 年 1 月至 3 月进行。该人群包括居住在加纳和欧洲的加纳人。
异常的 SUA 水平。
使用逻辑回归检查 SUA 四分位间距与微血管(蛋白尿)和大血管(外周动脉疾病和冠状动脉疾病)功能障碍的关联,调整了年龄、性别、估计肾小球滤过率、居住地点、社会经济地位、酒精、吸烟、糖尿病、高血压、腰围-臀围比和总胆固醇水平。进行中介分析以评估该关联是否通过血压升高、糖化血红蛋白和高敏 C 反应蛋白水平或通过体重-臀围比发生。研究问题是在数据收集后提出的。
共纳入 4919 名 25-75 岁(平均[标准差]46.26[11.08]岁)的加纳人(3047[61.9%]名女性)。在调整协变量后,SUA 四分位间距与蛋白尿呈显著正相关,但与冠状动脉疾病或外周动脉疾病无关。在充分调整后,SUA 四分位 4 的个体发生蛋白尿的可能性更高(调整后的优势比[OR],1.54;95%CI,1.07-2.21),但发生外周动脉疾病(OR,1.35;95%CI,0.87-2.08)或冠状动脉疾病(OR,1.09;95%CI,0.77-1.55)的可能性与四分位 1 的个体相比没有差异。在充分调整后,收缩压和舒张压显著介导了 SUA 浓度与蛋白尿之间的关联,占收缩压总关联的 19.4%,占舒张压总关联的 17.2%;糖化血红蛋白、高敏 C 反应蛋白和腰臀比不能介导这种关联。
在这项对撒哈拉以南非洲人群的横断面研究中,SUA 水平升高与肾脏微血管功能障碍显著相关,部分通过血压升高介导。这些发现表明,SUA 水平升高的撒哈拉以南非洲人群可能受益于定期筛查肾脏微血管功能障碍,以帮助早期发现或治疗。